On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, on executive retention of significant stock was not approved.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.14 USD | -1.45% | +2.17% | -19.85% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.85% | 84.63B | |
+43.38% | 750B | |
+34.11% | 606B | |
-6.42% | 356B | |
+18.95% | 326B | |
+6.60% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.10% | 167B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company